Joint

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Joint (JYNT) posts record sales in Q4 2022, eyes strategic growth

Joint (JYNT) delivered strong financial performance in Q4 2022, driven by record clinic openings and successful marketing initiatives.
While facing challenges such as labor costs and franchise sales impact, the company is focused on margin expansion and strategic growth opportunities.
With a positive outlook for 2023 revenue and adjusted EBITDA, Joint (JYNT) aims to navigate challenges and capitalize on opportunities for sustained success.
The company's commitment to patient care, operational efficiency, and financial planning positions it well for future growth and profitability.

Joint Corp. posts impressive Q1 results amidst digital marketing evolution

Joint Corp. delivered robust Q1 2023 results with strong sales growth and operational performance across its clinic network.
While facing competitive pressures and marketing challenges, the company's focus on efficiency and patient acquisition strategies bodes well for future growth.
Adapting to digital marketing trends and leveraging upcoming events can position Joint Corp. for sustained success and investor confidence.

Joint (JYNT) reports strong Q2 growth, focuses on profitability

Joint (JYNT) reported solid growth in system-wide sales and clinic openings, with profitability around 20% despite challenges.
The company is actively addressing operational issues, optimizing its clinic portfolio, and focusing on cost savings initiatives.
Strategic planning for profitability and efficiency in 2024 and beyond is underway, with a commitment to long-term success.
Partnerships, marketing expansions, and ongoing reviews present opportunities for growth and market expansion for Joint (JYNT).

The Joint Corp. reports stable Q3 earnings, shifts focus to franchises

The Joint Corp. delivered solid financial performance in Q3 2023, with a focus on refranchising and enhancing franchise clinic operations.
Efforts to boost new patient starts and optimize marketing strategies are driving positive trends in conversion rates and sales.
While facing challenges in new patient counts and franchise sales, the company is strategically positioning itself for long-term success.

The Joint Corp. reports robust 2023 performance and strategic growth plans

The Joint Corp. delivered strong financial performance in 2023, with notable growth in sales, revenue, and patient metrics.
Strategic initiatives like refranchising and local store marketing offer growth opportunities and cost-saving potential for the company.
Challenges include managing the transition of company-owned clinics and balancing marketing expenses with revenue growth objectives.
Overall, The Joint Corp. is well-positioned to capitalize on its operational strengths and market opportunities for sustained growth and success.

The Joint Corp. triples franchise sales and boosts financial performance

The Joint Corp. delivered strong financial performance in Q1 2024, marked by revenue growth, improved bottom line, and significant franchise sales growth, supported by robust marketing strategies.
While facing potential risks and challenges, the company's focus on EBITDA, franchise expansion, and talent development positions it well for future growth and operational excellence.
Opportunities in marketing innovation, talent development, and operational efficiency present avenues for sustained growth and value creation, aligning with the company's commitment to performance and brand enhancement.
Overall, The Joint Corp.'s Q1 2024 earnings call highlighted a strategic roadmap for success, emphasizing growth, excellence in patient care, and financial transparency to drive shareholder value.

The Joint Corp. reports revenue growth and strategic focus on clinics

The Joint Corp. reported positive revenue growth in Q2 2024, driven by same-store comps and operational improvements.
While facing financial challenges and impact on franchise sales, the company's strategic focus on clinic optimization and patient loyalty is a key strength.
Future opportunities lie in expanding the clinic network, enhancing profitability, and driving patient loyalty through innovative strategies.
Overall, The Joint Corp. is positioned for growth with a strong foundation of clinics and a focus on improving financial performance and patient experiences.

Joint Corp (JYNT) reports robust Q3 performance amidst operational enhancements

Joint Corp's Q3 2024 earnings call highlighted strong performance metrics, a strategic focus on patient care and operational efficiency, and challenges related to consumer headwinds and refranchising efforts. The company is well-positioned to capitalize on growth opportunities by leveraging its infrastructure and exploring new service offerings.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through the Corporate Clinics and Franchise Operations segments. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

Clinics Included in the May 6 Guidance of Opening 20 to 30 Corporate Clinics in 2021 Clinics Included in the May 6 Guidance of Opening 20 to 30 Corporate Clinics in 2021

The Joint Corp. Enters New Market, Opening the First Clinic in a Series of Six Planned Corporate Clinics

SCOTTSDALE, Ariz., June 3, 2021 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic ® network, welcomes Mark Miller as its new Vice President of Real Estate & Construction.

The Joint Corp. Hires New Vice President of Real Estate & Construction

Does The Joint Corp. (JYNT) have what it takes to be a top stock pick for momentum investors? Let's find out.

The Joint Corp. (JYNT) Is Up 9.86% in One Week: What You Should Know

The Joint Corp. 's (JYNT) resilient business model along with its long-term expansion plans makes it a perfect fit for your investment portfolio.

5 Solid Reasons Why The Joint (JYNT) Looks Attractive Now

SCOTTSDALE, Ariz., May 26, 2021 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), a national operator, manager, and franchisor of chiropractic clinics, announced that management will participate in the 18th Annual Craig-Hallum Institutional Investor Conference on Wednesday, June 2, 2021.

The Joint Corp. to Participate Virtually in the 18th Annual Craig-Hallum Institutional Investor Conference

The Joint Corp. (JYNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

The Joint Corp. (JYNT) Moves 17.8% Higher: Will This Strength Last?

SemiLEDs

Moxian BVI

Scopus BioPharma

Taiwan Liposome Company Ltd - ADR

These are 5 of the best stock gainers this past week that you should know about: SCPS, TLC, LEDS, JYNT, MOXC. The post 5 Stock Gainers This Past Week: SCPS, TLC, LEDS, JYNT, MOXC appeared first on Pulse 2.0.

5 Stock Gainers This Past Week: SCPS, TLC, LEDS, JYNT, MOXC

UP Fintech Holding

Markets were only marginally higher, but these companies had good news.

These 2 Hot Stocks Gave the Nasdaq a Boost Tuesday

Why The Joint Corp. Stock Jumped 15.5% Today

The stock price of Joint Corp (NASDAQ: JYNT) increased by over 10% pre-market. This is why it happened.

JYNT Stock Price: Over 10% Increase Pre-Market Explanation

SCOTTSDALE, Ariz., May 25, 2021 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ:JYNT), a national operator, manager, and franchisor of chiropractic clinics, announced the company has been selected by the S&P Dow Jones Indices to join the S&P SmallCap 600® effective prior to the opening of trading on Thursday, May 27, 2021.

The Joint Corp. Set to Join S&P SmallCap 600

It's clear that the momentum carrying this business is only getting stronger.

A Huge First Quarter From This Hot Stock Could Mean Strong Future Returns

SCOTTSDALE, Ariz., May 11, 2021 /PRNewswire/ -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic®  network, announces the opening of its 600th location.

The Joint Chiropractic Reaches Significant Goal

The Joint Corp. (JYNT) CEO Peter Holt on Q1 2021 Results - Earnings Call Transcript

The Joint Corp. (JYNT) delivered earnings and revenue surprises of 433.33% and 5.46%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

The Joint Corp. (JYNT) Q1 Earnings and Revenues Surpass Estimates

SCOTTSDALE, Ariz., May 5, 2021 /PRNewswire/ -- May is National Posture Month, making it the perfect time to discuss the importance of good posture and its impact on the spine and our overall health.

The Joint Chiropractic Promotes National Posture Month in May

The Joint Corp. (JYNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate The Joint Corp. (JYNT) to Report a Decline in Earnings: What to Look Out for

SCOTTSDALE, Ariz., April 22, 2021 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will report its first quarter 2021 financial results on Thursday, May 6, 2021, after the market close. President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. ET that day to discuss the results.

The Joint Corp. to Host Conference Call on Thursday, May 6th to Discuss First Quarter 2021 Results

On Monday, Joint got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96. The post Joint Sees Its Composite Rating Rise To 96; Stock Keeps Running Higher appeared first on Investor's Business Daily.

Joint Sees Its Composite Rating Rise To 96; Stock Keeps Running Higher

SCOTTSDALE, Ariz., April 06, 2021 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, reported corporate clinic activity that increased the number of company-owned or managed clinics to 74 as of April 1, 2021.

The Joint Corp. Acquires 8 Previously Franchised Clinics and Opens 2 Greenfield Clinics, Increasing the Corporate Portfolio to 74 Clinics

Joint Corp. stock has grown by >370% over the past year - a stunning achievement given the pandemic headwinds faced by the developer of Chiropracting franchises.

The Joint Corp.: Share Price May Be Headed For A Period Of Consolidation

Aviat Networks

Big 5 Sporting Goods

Clearfield

CTO Realty Growth

Superior Uniform Group

The Container Store

Meridian Bioscience

These eight small-cap stocks are affordable, and they can deliver significant returns, especially during an economic recovery. The post 8 Small-Cap Stocks With Plenty of Cred appeared first on InvestorPlace.

8 Small-Cap Stocks With Plenty of Cred

On Monday, Joint got an upgrade for its IBD SmartSelect Composite Rating from 90 to 96. The post Joint Joins Rank Of Stocks With 95-Plus Composite Rating appeared first on Investor's Business Daily.

Joint Joins Rank Of Stocks With 95-Plus Composite Rating

The Joint Corp (JYNT) CEO Peter Holt on Q4 2020 Results - Earnings Call Transcript

- Grows Revenue 23% Quarterly and 21% Annually, Compared to 2019 - - Reports Record Annual Operating Income of $5.5 Million, Up 61% Compared to 2019 - - Posts Record Adjusted EBITDA of $9.1 Million, Up 47% Compared to 2019 - - Increases Total Clinic Count to 579, Opening 21 Clinics in Q4 2020, Compared to 25 in Q4 2019 - - Sells Record 56 Franchise Licenses in Q4 2020, Up from 23 in Q4 2019 -

News for Joint Stock (JYNT)